GSA CAPITAL PARTNERS LLP - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 25 filers reported holding XENON PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$664
+22.3%
18,562
+34.9%
0.07%
-1.5%
Q4 2022$543
-99.4%
13,763
+2.8%
0.07%
+1016.7%
Q1 2016$94,000
-69.1%
13,384
-64.6%
0.01%
-60.0%
Q4 2015$304,000
-44.2%
37,791
-42.7%
0.02%
-44.4%
Q3 2015$545,000
+42.3%
65,941
+98.4%
0.03%
+80.0%
Q2 2015$383,000
+85.0%
33,244
+170.3%
0.02%
+87.5%
Q1 2015$207,00012,3000.01%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Ghost Tree Capital, LLC 790,000$12,071,0003.53%
GREAT POINT PARTNERS LLC 700,000$10,696,0002.49%
COMMODORE CAPITAL LP 579,432$8,854,0002.33%
ACUTA CAPITAL PARTNERS, LLC 417,409$6,378,0002.25%
DAFNA Capital Management LLC 406,535$6,212,0001.65%
Tri Locum Partners LP 264,134$4,036,0001.60%
Parkman Healthcare Partners LLC 311,207$4,755,0001.20%
Ghost Tree Capital, LLC 250,000$3,820,0001.12%
Nan Fung Group Holdings Ltd 197,880$3,024,0000.97%
BVF INC/IL 1,571,778$24,017,0000.94%
View complete list of XENON PHARMACEUTICALS INC shareholders